152 related articles for article (PubMed ID: 35521006)
1. A Real-World Comparative Effectiveness Analysis of Thromboprophylactic Use of Enoxaparin Versus Unfractionated Heparin in Abdominal Surgery Patients in a Large U.S. Hospital Database.
Veeranki SP; Xiao Z; Levorsen A; Sinha M; Shah B
Hosp Pharm; 2022 Feb; 57(1):121-129. PubMed ID: 35521006
[No Abstract] [Full Text] [Related]
2. Real-World Comparative Effectiveness and Cost Comparison of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin in 376,858 Medically Ill Hospitalized US Patients.
Veeranki SP; Xiao Z; Levorsen A; Sinha M; Shah BR
Am J Cardiovasc Drugs; 2021 Jul; 21(4):443-452. PubMed ID: 33313988
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity.
Amin A; Kartashov A; Ngai W; Steele K; Rosenthal N
Front Cardiovasc Med; 2023; 10():1163684. PubMed ID: 37396589
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure.
Amin AN; Kartashov A; Ngai W; Steele K; Rosenthal N
J Health Econ Outcomes Res; 2024; 11(1):44-56. PubMed ID: 38390025
[No Abstract] [Full Text] [Related]
5. Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients.
Samuel S; To C; Ling Y; Zhang K; Jiang X; Bernstam EV
J Thromb Thrombolysis; 2023 Apr; 55(3):439-448. PubMed ID: 36624202
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
Amin AN; Lin J; Lenhart G; Schulman KL
Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial.
Pineo G; Lin J; Stern L; Subrahmanian T; Annemans L
J Hosp Med; 2012 Mar; 7(3):176-82. PubMed ID: 22058011
[TBL] [Abstract][Full Text] [Related]
8. Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis.
Samuel S; Li W; Dunn K; Cortes J; Nguyen T; Moussa D; Kumar A; Dao T; Beeson J; Choi HA; McCullough LD
J Thromb Thrombolysis; 2023 May; 55(4):617-625. PubMed ID: 37029256
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients.
McGarry LJ; Stokes ME; Thompson D
Thromb J; 2006 Sep; 4():17. PubMed ID: 17005045
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.
Deitelzweig SB; Becker R; Lin J; Benner J
Thromb Haemost; 2008 Nov; 100(5):810-20. PubMed ID: 18989525
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Hemodialysis Patients.
Green MS; Tellor KB; Buckallew AR
Hosp Pharm; 2017 Oct; 52(9):623-627. PubMed ID: 29276299
[No Abstract] [Full Text] [Related]
12. Enoxaparin. A pharmacoeconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty.
Dunn CJ; Goa KL
Pharmacoeconomics; 1996 Aug; 10(2):179-90. PubMed ID: 10163420
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
14. Heparin versus enoxaparin for prevention of venous thromboembolism after trauma: A randomized noninferiority trial.
Olson EJ; Bandle J; Calvo RY; Shackford SR; Dunne CE; Van Gent JM; Zander AL; Sikand H; Bongiovanni MS; Sise MJ; Sise CB
J Trauma Acute Care Surg; 2015 Dec; 79(6):961-8; discussion 968-9. PubMed ID: 26317819
[TBL] [Abstract][Full Text] [Related]
15. Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting.
Menon H; Pillai A; Aussenberg-Rodriguez J; Ambrose J; Youssef I; Griffiths EA; Al Ustwani O
Avicenna J Med; 2018; 8(4):133-138. PubMed ID: 30319954
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
[TBL] [Abstract][Full Text] [Related]
17. Short-term therapy with enoxaparin or unfractionated heparin for venous thromboembolism in hospitalized patients: utilization study and cost-minimization analysis.
Argenta C; Ferreira MA; Sander GB; Moreira LB
Value Health; 2011; 14(5 Suppl 1):S89-92. PubMed ID: 21839908
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight Heparin (enoxaparin) versus unfractionated heparin for venous thromboembolism prophylaxis in patients undergoing craniotomy.
Kandula V; Shah PV; Thirunavu VM; Yerneni K; Karras C; Abecassis ZA; Hopkins B; Bloch O; Potts MB; Jahromi BS; Tate MC
Clin Neurol Neurosurg; 2022 Dec; 223():107482. PubMed ID: 36283281
[TBL] [Abstract][Full Text] [Related]
19. Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients.
DeBiase C; Giuliano CA; Doshi M; Ganoff M; Alexander Paxton R
Pharmacotherapy; 2021 May; 41(5):424-429. PubMed ID: 33641194
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Venous Thromboembolism Prophylactic Measures Post Coronary Artery Bypass Graft Surgery.
Wilsey HA; Pandya K; Beavers C; Xiaoshu L; Ather A
Am J Cardiovasc Drugs; 2019 Dec; 19(6):589-595. PubMed ID: 31203501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
